Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Nu Holdings Ltd (NU) vs Oruka Therapeutics Inc. Common Stock (ORKA) Price & Performance

Nu Holdings LtdTrade
Oruka Therapeutics Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Nu Holdings Ltd vs Oruka Therapeutics Inc. Common Stock — how do they compare? Nu Holdings Ltd trades at $14.63 (market cap $75.26B), while Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.18B). The key difference: Nu Holdings Ltd is far larger — about 14.5× Oruka Therapeutics Inc. Common Stock's market cap, and Oruka Therapeutics Inc. Common Stock is trading nearer its 52-week high, Nu Holdings Ltd nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Nu Holdings Ltd for 53 Days and Oruka Therapeutics Inc. Common Stock for 0 Days on average.

NUORKA
Market Cap
$75.26B$5.18B
Volume
60,119,584490,798
Sector
FinancialsHealth
52-Week High
$18.76$113.08
52-Week Low
$11.60$26.19
Typical Hold Time
53 Days0 Days
Enterprise Value
$97.88B$4.31B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Nu Holdings Ltd

NU stock trades at $14.93, down 6.75% over 24 hours amid recent volatility. The technical outlook is bullish based on moving averages, though the 6-day RSI at 88.3 suggests overbought conditions. Fundamentally, the company shows strong growth with revenue rising from $3.0B in 2022 to $10.63B in 2025 and net income margin improving to 26.99%. Recent news includes denial of Monzo acquisition talks, causing price swings.

The outlook remains positive given robust fundamentals and analyst consensus, but risks include high valuation multiples, credit concentration, and acquisition speculation volatility. Upside to the $16.53 price target offers potential, though investor caution is warranted near technical resistance.

Oruka Therapeutics Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

NU
18% Buy82% Sell
Avg holding period · 53 Days
ORKA
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Nu Holdings Ltd

Nu Holdings Ltd is engaged in providing digital banking services. It offers several financial services such as Credit cards, Personal Account, Investments, Personal Loans, Insurance, Mobile payments, Business Account, and Rewards.

Read more on NU →

About Oruka Therapeutics Inc. Common Stock

Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.

Read more on ORKA →